Biomerica (BMRA) Other Working Capital Changes (2010 - 2026)
Biomerica (BMRA) reported Other Working Capital Changes of -$240000.0 for Q1 2026, down 189.16% on a YoY basis from $269189.2 in Q1 2025, and down 900.0% sequentially from -$24000.0 in Q4 2025.
Biomerica (BMRA) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 5 years of Other Working Capital Changes data on file, last reported at -$240000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 189.16% year-over-year to -$240000.0; the trailing twelve-month figure through Feb 2026 stood at -$350000.0 (down 11766.67% YoY), and the FY2025 full-year result was -$327000.0, down 1408.0% from the prior year.
- Other Working Capital Changes declined to -$240000.0 in Q1 2026, from -$24000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $198000.0 in Q1 2023 to a low of -$843631.0 in Q1 2022.
- A 5-year average of -$50321.2 and a median of -$9000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 106.7% in 2023 and plunged 189.16% in 2026, its largest moves.
- Tracing BMRA's Other Working Capital Changes over 5 years: stood at -$233000.0 in 2022, then soared by 68.24% to -$74000.0 in 2023, then declined by 9.46% to -$81000.0 in 2024, then jumped by 70.37% to -$24000.0 in 2025, then sank by 900.0% to -$240000.0 in 2026.
- Business Quant data shows BMRA's Other Working Capital Changes at -$240000.0 in Q1 2026, -$24000.0 in Q4 2025, and -$1000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 62,000.00 |
| Feb 28, 2026 | 62,000.00 |
| Feb 28, 2026 | 62,000.00 |
| Nov 30, 2025 | 9,000.00 |
| Nov 30, 2025 | 9,000.00 |
| Nov 30, 2025 | 9,000.00 |
| Aug 31, 2025 | -87,000.00 |
| Aug 31, 2025 | -87,000.00 |
| Aug 31, 2025 | -87,000.00 |
| May 31, 2025 | 32,000.00 |
| May 31, 2025 | 32,000.00 |
| May 31, 2025 | 32,000.00 |
| Feb 28, 2025 | -9,000.00 |
| Feb 28, 2025 | -9,000.00 |
| Feb 28, 2025 | -9,000.00 |
| Nov 30, 2024 | 100,000.00 |
| Nov 30, 2024 | 100,000.00 |
| Nov 30, 2024 | 100,000.00 |
| Aug 31, 2024 | -106,000.00 |
| Aug 31, 2024 | -106,000.00 |